首页> 中文期刊>实用药物与临床 >熊去氧胆酸与S-腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症

熊去氧胆酸与S-腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症

     

摘要

Objective To investigate the effect of ursodeoxycholic acid(UDCA) and S-adenosyl-L-methionine (SAMe) on intrahepatic cholestasis of pregnancy(ICP),and to observe the change rules of blood biochemical parameters during the treatment.Methods 84 hospitalized ICP patients were chosen and given UDCA 250 mg(4 times daily)orally + SAMe 1 500 mg(once daily)in slow running infusion for 7 d.Blood biochemical parameters were compared.Results The total bile acid,glycocholic acid,total bilirubin,direct bilirubin and aspartate aminotransferase decreased obviously in ICP patients after treatment(P < 0.01).There was a low positive correlation(r =0.29,P < 0.05) between glycocholic acid and aspartate aminotransferase.Conclusion The clinical effect of UDCA and SAMe in the treatment of intrahepatic cholestasis of pregnancy is good.The blood biochemical parameters can be used as the practical clinical indexes for the ICP patients.%目的 探讨熊去氧胆酸与S-腺苷蛋氨酸联合治疗妊娠期肝内胆汁淤积症(ICP)的疗效及血生化参数变化规律.方法 以84例ICP患者为研究对象,给予S-腺甘蛋氨酸静滴1 500 mg/d+熊去氧胆酸250mg4次/d口服治疗,比较治疗前后的血生化参数.结果 治疗后,ICP患者总胆汁酸、甘胆酸、总胆红素、直接胆红素、天门冬氨酸氨基转移酶降低,与治疗前比较,差并有统计学意义(P<0.01).血浆甘胆酸水平与天门冬氨酸氨基转移酶之间呈低度正相关(r=0.29,P<0.05).结论 S-腺甘蛋氨酸、熊去氧胆酸治疗ICP疗效良好,血生化参数是对妊娠期肝内胆汁淤积症疗效评价的实用临床指标.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号